Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01
Published November 7, 2018 · Recall initiated: October 22, 2018
Summary
FDA records drug Class II recall D-0128-2019, published November 7, 2018 and initiated October 22, 2018. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 1,380 100-count bottles; Lot: Lot: 757739, EXP 9/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: OOS resultsduring routine stability testing
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Distributor
- Distributed nationwide in the USA and Puerto Rico
- Lot
- Lot: 757739, EXP 9/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASynjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60July 8, 2026
- FDAJARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDCMarch 29, 2023
- FDAMicardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37),June 9, 2021
- FDACatapres (clonidine hydrochloride, USP) 0.2 mg, tablet, 100-count bottle, Rx only, Dist. by: BoehringerNovember 4, 2020
- FDAIrbesartan Bulk Active Pharmaceutical Ingredient.November 7, 2018
- FDAMorphine (1 mg/mL) in NS 100 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella ofNovember 7, 2018
Questions about this recall
Was Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01 recalled?
Yes. FDA published recall D-0128-2019 on November 7, 2018. Reported hazard: Failed Dissolution Specifications: OOS resultsduring routine stability testing
What should I do if I have this product?
Voluntary: Firm initiated · Letter